Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus
Open accessThe DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV) is a novel coronavirus that causes a highly contagious respiratory disease, SARS, with significant mortality. Although factors contributing to the highly pathogenic nature of SARS-CoV remain poorly understood, it has been reported that SARS-CoV infection does not induce type I interferons (IFNs) in cell culture. However, it is uncertain whether SARS-CoV evades host detection or has evolved mechanisms to counteract innate host defenses. We show here that infection of SARS-CoV triggers a weak IFN response in cultured human lung/bronchial epithelial cells without inducing the phosphorylation of IFN-regulatory factor 3 (IRF-3), a latent cellular transcription factor that is pivotal for type I IFN synthesis. Furthermore, SARS-CoV infection blocked the induction of IFN antiviral activity and the up-regulation of protein expression of a subset of IFN-stimulated genes triggered by double-stranded RNA or an unrelated paramyxovirus. In searching for a SARS-CoV protein capable of counteracting innate immunity, we identified the papain-like protease (PLpro) domain as a potent IFN antagonist. The inhibition of the IFN response does not require the protease activity of PLpro. Rather, PLpro interacts with IRF-3 and inhibits the phosphorylation and nuclear translocation of IRF-3, thereby disrupting the activation of type I IFN responses through either Toll-like receptor 3 or retinoic acid-inducible gene I/melanoma differentiation-associated gene 5 pathways. Our data suggest that regulation of IRF-3-dependent innate antiviral defenses by PLpro may contribute to the establishment of SARS-CoV infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“(ii) the papain‐like protease domain of CoV‐NL63 binds BECN1 and STING1, thus hindering BECN1‐mediated autophagosome formation and inhibiting IFN production (Devaraj et al, 2007; Chen et al, 2014)”
From Autophagy in major human diseases (2021) · cites this paper as Devaraj et al, 2007
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Ksiazek, T. G., Erdman, D., Goldsmith, C. S., Zaki, S. R., Peret, T., Emery, S., Tong, S., Urbani, C., Comer, J. A., Lim, W., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030781 · Cited by 4,344
Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444
Seth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329
Self-citationIKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562
5'-Triphosphate RNA Is the Ligand for RIG-I
Hornung, V., Ellegast, J., Kim, S., Brzózka, K., Jung, A., Kato, H., Poeck, H., Akira, S., Conzelmann, K.-K., Schlee, M., et al. (2006) · Science · doi:10.1126/science.1132505 · Cited by 2,474
Cited by
Items 301–400 of 413
Shepard, J. D., Freitas, B. T., Rodriguez, S. E., Scholte, F. E. M., Baker, K., Hutchison, M. R., Longo, J. E., Miller, H. C., O’Boyle, B. M., Tandon, A., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.794664 · Cited by 8
Kocic, G. M., Sokolovic, D. T., Jevtović−Stoimenov, T., Veljković, A., Kocić, R., Nikolić, G. M., Bašić, J., Stojanović, D. B., Cencic, A., & Stojanović, S. (2010) · Redox Report · doi:10.1179/174329210x12650506623564 · Cited by 8
Exploring the binding dynamics of covalent inhibitors within active site of PLpro in SARS-CoV-2
Patel, D. K., Kumar, H., & Sobhia, M. E. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108132 · Cited by 7
Choudhury, S. R., Moulick, D., Borah, A., Saikia, P., & Mazumder, M. K. (2021) · In Silico Pharmacology · doi:10.1007/s40203-021-00085-y · Cited by 7
Shi, X., Chen, J., Xing, G., Zhang, X., Hu, X., Zhi, Y., Guo, J., Wang, L., Qiao, S., Lu, Q., et al. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.10.003 · Cited by 8
Knaap, R. C. M., Fernández‐Delgado, R., Dalebout, T. J., Oreshkova, N., Bredenbeek, P. J., Enjuanes, L., Sola, I., Snijder, E. J., & Kikkert, M. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/751578 · Cited by 7
Liu, Y., Lu, T., Li, C., Wang, X., Chen, F., Yue, L., & Jiang, C. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1267903 · Cited by 7
IFI16 Positively Regulates RIG-I-Mediated Type I Interferon Production in a STING-Independent Manner
Shi, X., Wei, M., Feng, Y., Yang, Y., Zhang, X., Chen, H., Xing, Y., Wang, K., Wang, A., Wang, L., et al. (2024) · DNA and Cell Biology · doi:10.1089/dna.2023.0362 · Cited by 6
Gomes, B. A., Fernandes, D. A., da Fonseca, T. S., Campos, M. F., Jural, P. A., Silva, M. V. T. E., Constant, L. E. C., da Veiga, A. A. S., Ferreira, B. R., Magalhães, E. S., et al. (2025) · Drugs and Drug Candidates · doi:10.3390/ddc4020027 · Cited by 7
Saha, C., Laha, S., Chatterjee, R., & Bhattacharyya, N. P. (2021) · Non-Coding RNA · doi:10.3390/ncrna7040074 · Cited by 6
Regulation of virus-triggered type I interferon signaling by cellular and viral proteins
Zhong, B., Wang, Y., & Shu, H. (2010) · Frontiers in Biology · doi:10.1007/s11515-010-0013-x · Cited by 6
“…et al., 2008 Rotavirus NSP1 IRF3, IRF5, IRF7 destabilization of targets Barro and Patton, 2007 SARS-Coronavirus PLpro IRF3 proteasomal degradation of IRF3 Devaraj et al., 2007 foot-and-mouth disease virus Lpro NF-κB degradation of p65 and/or RelA Roy and Mocarski, 2007 Kaposi’s…”
BackgroundInnate Immune Priming by cGAS as a Preparatory Countermeasure Against RNA Virus InfectionPreprint
Parker, M. T., Gopinath, S., Perez, C. E., Linehan, M. M., Crawford, J. M., Iwasaki, A., & Lindenbach, B. D. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/434027 · Cited by 6
Negm, A., Rabee, A. R., Abdel‐Hamid, H., Nasr, S. A., Ghareeb, D. A., Ibrahim, R. S., Hawsawi, M. B., Abdelmoneim, A. M., Ismail, M. M. F., & Ayoup, M. S. (2025) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s106816202460572x · Cited by 5
Targeting the S1′ Pocket of SARS-CoV-2 Papain-Like Protease Yields Highly Potent Inhibitors
Garad, D. N., Li, X., Chua, T. K., Moku, B., Mishra, C. B., & Song, Y. (2025) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.5c00482 · Cited by 5
How SARS-CoV-2 dodges immune surveillance and facilitates infection: an analytical review
Wang, Q., Wu, X., Mao, Q., Gao, F., Liu, M., Song, Z., Bian, L., & Liang, Z. (2022) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.2078307 · Cited by 5
“In addition, PLpro, which is an essential papain-like protease in coronaviruses and is responsible for viral polyprotein processing and removing post-translational modifications on host proteins such as ubiquitin and Nedd8 [42], catalyzes deISGylation via direct interaction with MDA5 to hinder the immune response [41].”
BackgroundSARS-CoV-2 and UPS with potentials for therapeutic interventions
Ferdoush, J., Kadir, R. A., Kaplanoğlu, S., & Osborn, M. (2024) · Gene · doi:10.1016/j.gene.2024.148377 · Cited by 5
Mechanism, structural and functional insights into nidovirus-induced double-membrane vesicles
Wang, X., Chen, Y., Qi, C., Li, F., Zhang, Y., Zhou, J., Wu, H., Zhang, T., Qi, A., Ouyang, H., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1340332 · Cited by 6
Protić, S., Popović, M. C., Kaličanin, N., Prodanović, O., Senćanski, M., Milićević, J. S., Stevanović, K. Z., Perović, V., Paessler, S., Prodanović, R., et al. (2024) · ChemistryOpen · doi:10.1002/open.202400091 · Cited by 5
Li, S. U. N., Yang, Y.-D., Dian-Bo, L. I. U., Xing, Y., Chen, X., & Chen, Z. (2010) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2010.00111 · Cited by 5
Self-citationJunaid, M., Akter, Y., Siddika, A., Nayeem, S. M. A., Nahrin, A., Afrose, S. S., Ezaj, M. M. A., & Alam, M. S. (2021) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557521666210805113231 · Cited by 5
Cytokine-independent induction of LGP2/DHX58 in viral infection
Liu, Y., Tong, X., Wang, R., Li, Z. G., Xie, Z., Wang, D., Gu, W., & Li, K. (2025) · Journal of General Virology · doi:10.1099/jgv.0.002173 · Cited by 4
“…three viral dsRNA-sensing pathways – Toll-like receptor 3 (TLR3, recognizing extracellular dsRNA), RIG-I and MDA5 (sensing cytoplasmic dsRNA) – that impart robust antiviral gene expression and, as such, have been widely used to study factors that regulate these innate immune mechanisms [6, 29, 30].”
Self-citationSrivastava, R., Panda, S. K., Gupta, P. S. S., Chaudhary, A., Naaz, F., Yadav, A. K., Ram, N. K., Rana, M. K., Singh, R. K., & Srivastava, R. (2023) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2297005 · Cited by 4
“PLpro is a multifunctional protein that aids in viral replication, disrupts the host’s innate immune response and inhibits interferon (IFN) production (Devaraj et al, 2007; Rut et al., 2020).”
Woo, H. S., Lee, K. H., Park, K. H., & Kim, D. W. (2024) · Plants · doi:10.3390/plants13233319 · Cited by 4
“Potential functions of PLpro beyond viral peptide cleavage have been proposed by recent structural and functional studies, including deubiquitination, deISGylation, and immune response evasion [6–8].”
Distinct Molecular Mechanisms Characterizing Pathogenesis of SARS-CoV-2
Lee, S. J., Kim, Y., & Ahn, D. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2206.06064 · Cited by 5
Virus-induced deconjugation of ISG15 dysregulates innate immunity and cellular metabolism
Zhu, J., Liu, G., Xu, J., Sayyad, Z., Li, K., Chakraborty, S., Goins, C. M., Yu, H., Zhou, Y., Ross, S., et al. (2026) · Immunity · doi:10.1016/j.immuni.2026.07.007 · Cited by 3
Self-citationWang, Z., Zhou, M., Fu, Z., & Zhao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.693579 · Cited by 3
“Yuen et al. suggested the function of nsp13, nsp14, nsp15 to quell IRF3 nuclear localization (40) and further studies are required to elucidate those mechanisms.”
MethodInfluentialWells, E. W., & Parker, M. T. (2023) · Health Security · doi:10.1089/hs.2023.0008 · Cited by 4
Regulation of Antiviral Innate Immune Responses by Human Coronavirus*
Li, S. U. N., Dian-Bo, L. I. U., Yu-Dong, Y. A. N. G., Ya-Ling, X. I. N. G., Xiao-Juan, C. H. E. N., & Zhong-Bin, C. H. E. N. (2010) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2009.00462 · Cited by 3
Self-citationLosartan promotes cell survival following SARS-CoV-2 infection in vitroPreprint
Nejat, R., Sadr, A. S., Freitas, B. T., Crabtree, J. M., Pegan, S. D., Tripp, R. A., & Najafi, D. J. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.27.424507 · Cited by 3
Mutational Analysis of SARS-CoV-2. ORF8 and the Evolution of the Delta and Omicron VariantsPreprint
Trieu, G., Ng, K., & Trieu, V. N. (2021) · SSRN Electronic Journal · doi:10.1101/2021.12.19.21268069 · Cited by 4
Ubiquitination: A Double‐Edged Mechanism in Coronavirus Infections
Liu, S., Shao, C., Ding, Y., Wang, Y., Jin, L., Tan, D., Li, S., Deng, X., Zhou, Y., & Xia, Z. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70589 · Cited by 2
“They utilize the deubiquitinase activity of their own protein PL pro , which is common in coronaviral infections [156, 157].”
Shi, X., Chen, H., Xing, Y., Wang, K., Zhang, X., Fan, X., Zhang, Y., Wang, Y., Peng, S., Wang, A. R., et al. (2026) · BMC Veterinary Research · doi:10.1186/s12917-025-05230-9 · Cited by 2
“Overexpression of RIG-N (the constitutively active form of RIG-I), MAVS, TRIF, IKK-ε, or IRF3(5D) (a phosphomimetic mutant of IRF3) can induce IFN-β promoter activation [28, 29, 43].”
Nan, J., Shuai, H., Qiao, J., Zeng, R., Du, L., Chen, Y., Yoon, C., Hu, J., Guo, W., Wang, L., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68795-5 · Cited by 2
Coronaviruses and Arteriviruses
Narayanan, K., & Makino, S. (2014) · ASM Press eBooks · doi:10.1128/9781555815561.ch23 · Cited by 2
Coronavirus Papain-like Peptidases
Ratia, K. M., Mesecar, A. D., O’Brien, A., & Baker, S. C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382219-2.00493-2 · Cited by 2
Self-citationProtective Role of the Host Innate Immune System in Prion Pathogenesis
Ishibashi, D. (2019) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.18-00165-2 · Cited by 2
Zheng, P., Yuan, W., Xiao, X., Xiong, K., Li, X., Holck, A. L., & Liu, R. (2020) · ES Food & Agroforestry · doi:10.30919/esfaf0012 · Cited by 2
Coronavirus (CoV) proteins (version 2020.4) in the IUPHAR/BPS Guide to Pharmacology Database
Alexander, S. P. H., Ball, J. K., & Tsoleridis, T. (2020) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f1034/2020.4 · Cited by 2
Fundamental aspects of the structural biology of coronaviruses
Lara-Hernández, I., Coronado-Ipiña, M. Á., Rocha-Rosas, K., & Comas‐García, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90248-9.00011-5 · Cited by 2
Beltz, L. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98809-4.00013-9 · Cited by 2
Iraldo, B.-R., Hernández‐Bernal, F., Nodarse-Cuní, H., Duncan-Roberts, Y., Martínez-Suárez, C., Campa-Legrá, I., Moynelo, I. E., Muzio‐González, V. L., & Guillén, G. E. (2020) · Research Square · doi:10.21203/rs.3.rs-28958/v1 · Cited by 2
Viral deubiquitinases and innate antiviral immune response in livestock and poultry
Zhengxuan, Z. H. O. U., Xu, J., Li, Z., Yan, L. V., Wu, S., Zhang, H., Song, Y., & Ai, Y. (2021) · Journal of Veterinary Medical Science · doi:10.1292/jvms.21-0199 · Cited by 1
“This DUB activity has been implicated in the downregulation of cellular innate immune responses [17], consistent with the observation that SARS-CoV infection prevents IFN-β induction in infected cells [63].”
ResultRut, W., Groborz, K. M., Sun, X., Hilgenfeld, R., & Drąg, M. (2024) · Protein Science · doi:10.1002/pro.5139 · Cited by 2
“Additionally, viral proteases are often involved in evading host immune responses by cleaving host proteins involved in antiviral defense mechanisms (Clementz et al., 2010; Devaraj et al., 2007; Frieman et al., 2009; Lei & Hilgenfeld, 2017; Mukherjee et al., 2011).”
Tuluk, T., Kankılıç, T., Civelek, İ., Akın, D. F., & Bankır, M. (2024) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2024-0139 · Cited by 1
Al-Homoudi, A. I., Kushwaha, N. D., Aruri, H., Galarza, D., Moorman, N. J., Heise, M. T., Tartamella, J., Ray, D., Kovari, L. C., & Gavande, N. S. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119108 · Cited by 1
Tiwari, S., Mishra, R. K., Basak, S., & Pandey, R. (2025) · iScience · doi:10.1016/j.isci.2025.113716 · Cited by 1
“…(IAV) 70 inhibit NF-κ B. Highly pathogenic viruses, such as Ebola virus, certain coronaviruses, and paramyxovi-ruses target both IRF-3 and NF-κ B. 65,71 However, not all viruses show antagonism to these pathways and are believed to activate NF-κ B and IRF-3 signaling cascades during infection…”
Shi, X., Xing, Y., Chen, H., Wang, K., Zhang, X., Fan, X., Zhang, Y., Wang, Y., Peng, S., Wang, A., et al. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108102 · Cited by 2
Pattis, J. G., Elokely, K. M., & Gianti, E. (2025) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-025-00730-0 · Cited by 1
“…viral polyprotein after the P1 glycine, releasing nsp1, nsp2, and nsp3 for viral replication, and (2) hydrolysis of isopeptide bonds following the LXGG motif at the C-terminus of cellu - lar Ub and ISG15 [4, 5], thereby modulating innate immune responses during infection and pathogenesis [13–15].”
InfluentialTong, X., wang, R., Liu, Y., Potts, M. B., Pruett‐Miller, S. M., Whitt, M. A., Gu, W., & Li, K. (2026) · Pathogens · doi:10.3390/pathogens15040404 · Cited by 1
“Due to its high sensitivity to IFNs’ antiviral action, VSV is a long-established tool to gauge IFN antiviral activity in the form of plaque reduction assays and to investigate the effects of cellular and viral factors that regulate IFN immune signaling pathways [14–21].”
Self-citationPapain-like 2 protease of coronavirus and innate immune response
Jeon, Y. J. (2020) · Medical Biological Science and Engineering · doi:10.30579/mbse.2020.3.2.31 · Cited by 1
“SARS-CoV PL2 has been proposed to bind IRF3 and block its phosphorylation, dimerization, and nuclear translocation, and thereby inhibit IFN-b induction [19].”
BackgroundMolecular Multi-target Approach on COVID-19 for Designing Novel Chemicals
Kumar, P., & Ghosh, I. (2021) · Methods in pharmacology and toxicology · doi:10.1007/7653_2020_52 · Cited by 1
(1956) · Annual Review of Microbiology · doi:10.1146/annurev.mi.10.073106.100001 · Cited by 1
Insights into Coronavirus Papain-like Protease Structure, Function and Inhibitors
Jin, S., & Zhang, M. (2022) · Protein and Peptide Letters · doi:10.2174/0929866529666220602094016 · Cited by 1
Nayak, D., Bury, P. D. S., Drąg, M., Nijkerk, A. N., Oualid, F. E., & Olsen, S. K. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2803-4_11 · Cited by 1
COVID-19 Comorbidity and Metabolic Syndrome: Is There a Molecular Basis?Preprint
Basu, M., Saha, C., Choudhury, K. R., Dutta, S., Ghosh, S. K., Chowdhury, S., Mukhopadhyay, S., & Bhattacharyya, N. P. (2020) · Preprints.org · doi:10.20944/preprints202006.0245.v1 · Cited by 1
SARS-CoV-2 PLpro whole human proteome cleavage prediction and enrichment/depletion analysisPreprint
Prescott, L. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.04.462902 · Cited by 1
Kilianski, A. (2014) · Loyola eCommons (Loyola University of Chicago) · Cited by 1
Toll-Like Receptors: Novel Molecular Targets for Antiviral Immunotherapy
Razonable, R. R., Eid, A. J., & Hénault, M. (2014) · ASM Press eBooks · doi:10.1128/9781555815493.ch19
Development of Instantaneous Protection against SARS-CoV with Implications for Multiple RNA Viruses
Elshabrawy, H. A. (2012) · Figshare
Genetic determinants of virulence for the A59 and JHM strains of mouse hepatitis virus
Cowley, T. J. (2010) · ScholarlyCommons (University of Pennsylvania)
Evasion of MDA5-Mediated Innate Immunity by Paramyxoviruses
Davis-Gardner, M. E. (2015) · Digital Access to Scholarship at Harvard (DASH) (Harvard University) · Cited by 1
Severe acute respiratory syndrome-coronavirus and human coronavirus-NL63: an updated overview
Ditt, V., & Schildgen, O. (2009) · Reviews in Medical Microbiology · doi:10.1097/mrm.0b013e328331ad24
“In other studies, it could be observed that NSP1 affects the signalling pathways by blocking STAT1 phosphorylation and IRF3 dimerization [57].”
BackgroundInfluentialTotura, A. L. (2014) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/vkmg-md36 · Cited by 1
袁, 芃. (2018) · Advances in Microbiology · doi:10.12677/amb.2018.72005
PROPERTIES AND PATHOGENESIS OF CORONAVIRUSES
Kwiatek, A. (2020) · Kosmos · doi:10.36921/kos.2020_2669
Liberty and Pandemics: A Libertarian Approach to the Global COVID-19 SituationPreprint
Asudemade, H. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3630126
“SARS-CoV PLpro disrupts NF-κB signalling 73 and blocks the phosphorylation of IRF3 indirectly 73, 74 .”
BackgroundSars-Cov-2 And Betacoronavirus : What Have We Learned In 8 Months?
Kwiatek, A., & Adamczyk-Popławska, M. (2020) · Postępy Mikrobiologii - Advancements of Microbiology · doi:10.21307/pm-2020.59.3.14
Iraldo, B.-R., Hernández‐Bernal, F., Nodarse-Cuní, H., Duncan-Roberts, Y., Martínez-Suárez, C., Campa-Legrá, I., Moynelo, I. E., Muzio‐González, V. L., & Guillén, G. E. (2020) · Research Square · doi:10.21203/rs.3.rs-28958/v2
Molecular-Level Targets for the Development of Therapies Against Coronavirus Diseases
Zhou, Q. A., Granet, R., & Garner, L. V. (2021) · Methods in pharmacology and toxicology · doi:10.1007/7653_2020_64
Smoking Products Suppress Type I IFN During SARS-Cov-2 Infection
Lu, Z. (2021) · E3S Web of Conferences · doi:10.1051/e3sconf/202129203095
Coronavirus (CoV) proteins in GtoPdb v.2021.3
Alexander, S. P. H., Ball, J. K., & Tsoleridis, T. (2021) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f1034/2021.3
(1972) · Annual Review of Microbiology · doi:10.1146/annurev.mi.26.080206.100001
Gottesman, S. (2014) · Annual Review of Microbiology · doi:10.1146/annurev-mi-68-082814-100001
Gottesman, S. (2013) · Annual Review of Microbiology · doi:10.1146/annurev-mi-67-082213-100001
(1971) · Annual Review of Microbiology · doi:10.1146/annurev.mi.25.080106.100001
Ornston, L. N. (1997) · Annual Review of Microbiology · doi:10.1146/annurev.mi.51.080306.100001
Gottesman, S. (2010) · Annual Review of Microbiology · doi:10.1146/annurev-mi-64-090810-100001
(1961) · Annual Review of Microbiology · doi:10.1146/annurev.mi.15.080106.100001
Ornston, N. (2006) · Annual Review of Microbiology · doi:10.1146/annurev.mi.60.082206.100001
(1962) · Annual Review of Microbiology · doi:10.1146/annurev.mi.16.080106.100001
Ornston, L. N. (1996) · Annual Review of Microbiology · doi:10.1146/annurev.mi.50.080306.100001
Gottesman, S. (2012) · Annual Review of Microbiology · doi:10.1146/annurev-mi-66-092012-100001
Coronavirus (CoV) proteins in GtoPdb v.2022.2
Alexander, S. P. H., Ball, J. K., & Tsoleridis, T. (2022) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f1034/2022.2
Origin, evolution, and pathogenesis of coronaviruses
Rathod, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99596-2.00005-4 · Cited by 1
Coronavirus (CoV) proteins in GtoPdb v.2022.3
Alexander, S. P. H., Ball, J. K., & Tsoleridis, T. (2022) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f1034/2022.3
Rahimlou, B., Mohammadi, N. G., Rashidi, R., & Ghaffarpour, S. (2022) · Immunoregulation · doi:10.32598/immunoregulation.5.1.7
Coronavirus (CoV) proteins in GtoPdb v.2023.1
Alexander, S. P. H., Ball, J. K., & Tsoleridis, T. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f1034/2023.1
Mechanistic Insights on Viral Factors Involved in Asymptomatic COVID-19 Pathogenesis
Kaur, S., Bala, R., Mishra, P. C., Singh, V., & Hora, R. (2023) · Coronaviruses · doi:10.2174/2666796704666230913105109
Nanoparticles therapy: inspiration from the mechanism by which SARS-CoV-2 disrupts autophagy
Zhaojunli, W. A. N. G., Wang, Q., Ji, J., & Yuanyuan, Q. I. A. N. (2024) · Minerva Biotechnology and Biomolecular Research · doi:10.23736/s2724-542x.23.03013-4
Coronavirus (CoV) proteins in GtoPdb v.2023.3
Alexander, S. P. H., Ball, J. K., & Tsoleridis, T. (2023) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f1034/2023.3
Habeichi, N. J. (2023) · theses.fr (ABES) · doi:10.70675/0e67c54az3f91z48a4z8e84z7f89d5ecdbdf · Cited by 1
Pal, A., Roy, N. S., Angeliadis, M., Madhu, P., O’Reilly, S. R., Bera, I., Francois, N., Lynch, A., Gautier, V., Devocelle, M. C., et al. (2026) · Molecules · doi:10.3390/molecules31020282
Pradezynski, F. (2010) · theses.fr (ABES) · doi:10.70675/6453777czb873z4153za1d4z9ccc9e7c28a1
Biochemical insights into SARS-CoV replication
Subissi, L. (2014) · theses.fr (ABES) · doi:10.70675/927111f5zb24fz46c4zbdd7z84fe33fc8ce2
D'Orengiani, A.-L. P. H. D. (2014) · theses.fr (ABES) · doi:10.70675/85b003c5z09b3z47a1z9d43z4b2bc2c38c4a
“Nsp3 inhibits the IFN synthesis by antagonising IRF3 (IFN-regulatory factor 3), a key element in the IFN inducing pathway (Devaraj et al., 2007).”
Les méthyltransférases de la coiffe du MERS-CoV : étude fonctionnelle et recherches d'inhibiteurs
Aouadi, W. (2017) · theses.fr (ABES) · doi:10.70675/8e1435e3zc63az4f17z8e10zc76c0a7a533b
Metadata
- Authors
- Devaraj, S. G., Wang, N., Chen, Z., Chen, Z., Tseng, M., Barretto, N., Lin, R., Peters, C. J., Tseng, C.-T. K., Baker, S. C., & Li, K.
- Affiliations
- The University of Texas Medical Branch at Galveston (US)
- Loyola University Chicago (US)
- Lady Davis Institute for Medical Research (CA)
- Corresponding author
- Li, Kui
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-11
- Volume
- 282
- Issue
- 44
- Pages
- 32208-32221
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2756044
- OpenAlex
- W190626844
- Cited by
- 411
- References
- 80
- Citations by year
- 2026: 9 · 2025: 9 · 2024: 14 · 2023: 17 · 2022: 37 · 2021: 72 · 2020: 71 · 2019: 9 · 2018: 5 · 2017: 14 · 2016: 9 · 2015: 9 · 2014: 30 · 2013: 18 · 2012: 13
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4687 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01ai30039-19-0-2)
- National Institute on Drug Abuse (DA-018054, R21DA018054)
- National Institute of Allergy and Infectious Diseases (P01AI060915, AI060915, AI30039, AI-069285, AI 45798, AI057156, N01-AI-030039, U54AI057156, R01AI069285, R01AI045798)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- SARS-CoV, IRF3, papain-like protease, type I interferon, innate immune evasion, interferon antagonism, IRF3 phosphorylation, TLR3, IFN-stimulated genes, lung epithelial cells, viral pathogenesis
- MeSH terms
- Animals, Bronchi, Cell Line, Humans, Immunity, Innate, Interferon Type I, Peptide Hydrolases, Viral Proteins, Protein Structure, Tertiary, Severe Acute Respiratory Syndrome, Severe acute respiratory syndrome-related coronavirus, Interferon Regulatory Factor-3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.